|HAWPY -- USA Stock|| |
USD 35.24 0.00 0.00%
Dr. Lee Suan Yew is NonExecutive Independent Director of Haw Par Corporationrationration Ltd. He is a medical practitioner with over 50 years experience. He was appointed to the Board on 18 December 1995 and was last reappointed on 29 April 2016. He is a member of the Nominating Committee. Dr Lee is a Director of K1 Ventures Limited. He was appointed Justice of the Peace from 1998 2008. Dr Lee was President of the Singapore Medical Council for 4 years and was also Chairman of the Singapore National Medical Ethics Committee . For his numerous public services, he was awarded the Public Service Star in 1991 and Public Service Star in 2002. He holds a M.B.B. Chir. degree from the University of Cambridge and MRCP and FRCP from the Royal College of Physicians, Glasgow.
Age: 82 Director Since 1995 Ph.D
65 6337 9102 http://www.hawpar.com
The company has return on total asset (ROA)
of 1.6 %
which means that it generated profit of $1.6 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 4.34 %
meaning that it generated $4.34 on every $100 dollars invested by stockholders.
The company has accumulated 17.2 M in total debt with debt to equity ratio (D/E) of 0.7 which is about average as compared to similar companies. Haw Par Corporation Limited has Current Ratio of 5.41 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. Haw Par Corporation Limited was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug Manufacturers - Major classification in USA and traded on OTC Market. It employs 529 people.Haw Par Corporation Limited (HAWPY) is traded on OTC Market in USA. It is located in No. 03-03 Haw Par Technocentre and employs 529 people.
Haw Par Limited Leadership Team
|Sat Khattar, Independent Director|
|Siew Shiu, Acting Group Internal Audit Manager|
|Meng Kwek, Regional General Manager of Underwater World Singapore Pte Ltd / Haw Par Leisure Pte Ltd|
|Anthony Chang, Curator of Underwater World Singapore Pte Ltd|
|Swee Sim, Non-Executive Independent Director|
|Cho Wee, Non-Executive, Non Independent Chairman of the Board|
|Suan Lee, Non-Executive Independent Director|
|Chua Keeth, Deputy General Manager - Marketing of Haw Par Healthcare Limited|
|Wah Ng, Deputy General Manager-Manufacturing of Healthcare|
|Ah Han, Executive Director, Member of Investment Committee, General Manager of Haw Par Healthcare Limited and Director of Haw Par Healthcare Limited|
|Hiang Gn, Non-Executive Independent Director|
|Seok Lim, CFO and Company Secretary|
|Ee Wee, CEO and President Director, Member of Investment Committee, CEO of Haw Par Healthcare Limited and Acting President of Haw Par Healthcare Limited|
|Sien Tarn, General Manager - Corporate Development & Property Division|
|Mui Kow, Senior Manager-Quality & Regulatory Affairs of Healthcare|
|Sung Whang, General Manager of Underwater World Pattaya Ltd|
|Soo Hwang, Non-Executive Independent Director|
|Bee Goh, Director & General Manager - Manufacturing of Haw Par Healthcare Limited|
|Eechao Wee, Non-Executive Non Independent Director|
|Peter Chew, Deputy General Manager of Underwater World Singapore Pte Ltd|
|Kia Chew, Non-Executive Independent Director|
|Jasmin Hong, Deputy General Manager - Marketing of Haw Par Healthcare Limited|
Stock Performance Indicators
Macroaxis portfolio users are indifferent in their judgment towards investing in Haw Par Corporation Limited. What is your judgment towards investing in Haw Par Corporation Limited? Are you bullish or bearish?
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations